Skip to main content
. 2022 Jul 4;12:847793. doi: 10.3389/fonc.2022.847793

Table 1.

Relationship between KPNA2 expression and clinical characteristics of TSCC patients.

All cases KPNA2
Low expression High expression P
Gender
Female 44 16(36%) 28(64%) 0.2597
Male 80 20(25%) 60(75%)
Age
≥57.8 74 22(30%) 52(70%) 0.9948
<57.8 50 14(28%) 36(72%)
pT status
1 21 11(52%) 10(48%) 0.02892
2 43 9(21%) 34(79%)
3 33 6(18%) 27(82%)
4 19 5(26%) 14(74%)
pN status
0 48 12(25%) 36(75%) 0.3065
1 17 7(41%) 10(59%)
2 45 10(22%) 35(78%)
Stage
I 13 7(54%) 6(46%) 0.0498
II 19 2(11%) 17(89%)
III 29 8(28%) 21(72%)
IV 51 12(24%) 39(76%)
Tumor grade
1 17 9(53%) 8(47%) 0.04655
2 85 23(27%) 62(73%)
3 22 4(18%) 18(82%)

pT, posttreatment tumor category; pN, lymph node status; Stage, AJCC prognostic stage grouping; Tumor grade, Tumor grade is a way of classifying tumors based on certain features of their cells.

Grade 1. The tumor cells look the most like normal tissue and are slow-growing (well-differentiated).

Grade 2. The tumor cells fall somewhere in between grade 1 and grade 3 (moderately-differentiated).

Grade 3. The tumor cells look very abnormal and are fast-growing (poorly-differentiated).

Bolded p-values were two-sided with significance defined as a p-value < 0.05.